Cited by — Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations.
No admitted local citation edges point to this work yet.
